Market Research Logo

Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2018

Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2018 provides an overview of Hemostasis Rapid Tests & Point of Care (POC) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hemostasis Rapid Tests & Point of Care (POC) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hemostasis Rapid Tests & Point of Care (POC) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hemostasis Rapid Tests & Point of Care (POC) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hemostasis Rapid Tests & Point of Care (POC) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Hemostasis Rapid Tests & Point of Care (POC) Overview
3 Products under Development
3.1 Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
3.2 Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Segment
3.3 Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Territory
3.4 Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path
3.5 Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date
4 Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products under Development by Companies
4.1 Hemostasis Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development
4.2 Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
5 Hemostasis Rapid Tests & Point of Care (POC) Companies and Product Overview
5.1 Alere Inc Company Overview
5.1.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Atomo Diagnostics Pty Limited Company Overview
5.2.1 Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
5.3 Carclo Diagnostic Solutions Ltd Company Overview
5.3.1 Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.4 Cascade Metrix LLC Company Overview
5.4.1 Cascade Metrix LLC Pipeline Products & Ongoing Clinical Trials Overview
5.5 Edan Instruments Inc Company Overview
5.5.1 Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 EKF Diagnostics Holdings Plc Company Overview
5.6.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Helena Laboratories Corp Company Overview
5.7.1 Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview
5.8 Radiometer Medical ApS Company Overview
5.8.1 Radiometer Medical ApS Pipeline Products & Ongoing Clinical Trials Overview
5.9 Universal Biosensors Inc Company Overview
5.9.1 Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Hemostasis Rapid Tests & Point of Care (POC)- Recent Developments
6.1 Jun 14, 2018: EMOSIS Announces an Exclusive Distribution Agreement with 5-Diagnostics and the Start of Commercialization
6.2 Mar 20, 2018: EMOSIS Announces CE Mark Approval for HIT Confirm Kit
6.3 Sep 29, 2017: Alere Announces the U.S. Department of Justice Closes Investigation
6.4 Sep 28, 2017: Alere Announces Settlement with SEC
6.5 Aug 03, 2017: Alere Reports Second Quarter 2017 Financial Results
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
Table 2: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Segment
Table 3: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Territory
Table 4: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path
Table 5: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date
Table 6: Hemostasis Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development
Table 7: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
Table 8: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Afinion PT Test - Capillary Blood - Product Status
Table 10: Afinion PT Test - Capillary Blood - Product Description
Table 11: Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 12: AtomoRapid - Coagulation Monitoring - Product Status
Table 13: AtomoRapid - Coagulation Monitoring - Product Description
Table 14: Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Micropoc-CAT - Haemostasis Assay - Product Status
Table 16: Micropoc-CAT - Haemostasis Assay - Product Description
Table 17: Cascade Metrix LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Multiple Blood Analytes Test - Product Status
Table 19: Multiple Blood Analytes Test - Product Description
Table 20: Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: i15 - Coagulation Test - Product Status
Table 22: i15 - Coagulation Test - Product Description
Table 23: EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Point-Of-Care Test - Coagulation - Product Status
Table 25: Point-Of-Care Test - Coagulation - Product Description
Table 26: Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Cascade Abrazo - Activated Partial Thromboplastin Time (aPTT) - Product Status
Table 28: Cascade Abrazo - Activated Partial Thromboplastin Time (aPTT) - Product Description
Table 29: Cascade Abrazo - c-ACT - Product Status
Table 30: Cascade Abrazo - c-ACT - Product Description
Table 31: Cascade Abrazo - c-ACT-LR - Product Status
Table 32: Cascade Abrazo - c-ACT-LR - Product Description
Table 33: Cascade Abrazo - Direct Oral Anticoagulants Test - Product Status
Table 34: Cascade Abrazo - Direct Oral Anticoagulants Test - Product Description
Table 35: Cascade Abrazo - Direct Thrombin Inhibitors - Product Status
Table 36: Cascade Abrazo - Direct Thrombin Inhibitors - Product Description
Table 37: Cascade Abrazo - Fibrinogen - Product Status
Table 38: Cascade Abrazo - Fibrinogen - Product Description
Table 39: Cascade Abrazo - Heparin Titration - Product Status
Table 40: Cascade Abrazo - Heparin Titration - Product Description
Table 41: Cascade Abrazo - LMWH - Product Status
Table 42: Cascade Abrazo - LMWH - Product Description
Table 43: Cascade Abrazo - Protamine Titration - Product Status
Table 44: Cascade Abrazo - Protamine Titration - Product Description
Table 45: Cascade Abrazo - PT-C - Product Status
Table 46: Cascade Abrazo - PT-C - Product Description
Table 47: Radiometer Medical ApS Pipeline Products & Ongoing Clinical Trials Overview
Table 48: AQT90 FLEX - APTT Test - Product Status
Table 49: AQT90 FLEX - APTT Test - Product Description
Table 50: AQT90 FLEX - PT-INR Test - Product Status
Table 51: AQT90 FLEX - PT-INR Test - Product Description
Table 52: Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Diagnostic Assay - Coagulation - Product Status
Table 54: Diagnostic Assay - Coagulation - Product Description
Table 55: Glossary
1.2 List of Figures
Figure 1: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
Figure 2: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Segment
Figure 3: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Territory
Figure 4: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path
Figure 5: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report